| Application no. and date | 18811658.6 (espacenet) (Federated) (European Patent Register), 20181114 | | Patent/reg. no. and date | DK/EP 3713942, 20230308 | | Publication date | 20200930 | | Priority no. and date | US 201762589256 P, 20171121 | | EP pub. no. and date |
EP 3713942 20200930 | | Effective date | | | Applicant/owner | Pfizer Inc., 66 Hudson Boulevard East
New York, NY 10001-2192, US | | Applicant ref. no. | V455838DK00 | | Inventor | FERNANDO, Dilinie, 6 Driftwood Road
Jamaica Plain, Massachusetts 02130, US,
LACASSE, Shawn M., 72 Haley Meadow Road
Griswold, Connecticut 06351, US,
WIGLESWORTH, Kristin, 20037 Wanegarden Ct.
Germantown, Maryland 20874, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/438 (2006.01) , A61P 1/16 (2006.01) , A61P 3/10 (2006.01) , C07C 215/10 (2006.01) , C07D 471/10 (2006.01) | | Title | KRYSTALLINSK 2-AMINO-2-(HYDROXYMETHYL)PROPAN-1,3-DIOL-SALT AF 4-(4-(1-ISOPROPYL-7-OXO-1,4,6,7-TETRAHYDROSPIRO[INDAZOL-5,4'-PIPERIDIN]-1'-CARBONYL)-6-METHOXYPYRIDIN-2-YL)BENZOESYRE | | Int. application no. | IB2018058966 | | Int. publication no. | WO2019102311 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
